2026 NPPES data Retina Specialist (Ophthalmology) Physician NPI 1407274913 M.D.
Verify on CMS →

TAMER HADI, M.D.

Retina Specialist (Ophthalmology) Physician in SAN JOSE, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
504
Medicare Part D claims · 141 beneficiaries · Retina Specialist (Ophthalmology) Physician avg: 558
Generic prescribing
52%
generic claims · 48% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.9655/100
▲ 9 pts above national avg 83.1 · [object Object]
Industry payments
$67.82
3 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: TAMER HADI, M.D. is a Retina Specialist (Ophthalmology) Physician ([object Object]) practicing in SAN JOSE, California with a Medicare Part D prescribing footprint of 504 claims across 141 beneficiaries — 48% brand-name prescribing . Their CMS MIPS Final Score of 91.9655/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $67.82 across 3 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: TAMER HADI, M.D. reported a CMS MIPS final score of 91.9655 out of 100, above the 83.1 national average, and filed 504 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

TAMER HADI, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

TAMER HADI, M.D. at a glance

High performer (top quartile)

NPI registry status

Active

Issued 04/01/2014

NPI 1407274913

Primary specialty

Retina Specialist (Ophthalmology) Physician

Niche

913 US NPIs in this specialty

Medicare Part D claims

504 10% vs specialty avg

2023 prescription claims

Specialty avg: 558

MIPS final score

91.9655/100 8.865500000000011% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in California

How Retina Specialist (Ophthalmology) Physician compares to other specialties among California providers

California providers

Retina Specialist (Ophthalmology) Physician share within California

1. Retina Specialist (Ophthalmology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Retina Specialist (Ophthalmology) Physician share within California

Medicare quality performance — MIPS

TAMER HADI, M.D.'s 2023 MIPS final score plotted against the Retina Specialist (Ophthalmology) Physician national average

High performer (top quartile)
MIPS Final Score
91.9655/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Retina Specialist (Ophthalmology) Physician) — 91.9655/100 vs national avg 83.1

0%100%National avg83%92%
MIPS final score (Retina Specialist (Ophthalmology) Physician) — 91.9655/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

TAMER HADI, M.D. is a Retina Specialist (Ophthalmology) Physician provider practicing in SAN JOSE, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1407274913. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

TAMER HADI, M.D. appears in the CMS NPPES registry as a Retina Specialist (Ophthalmology) Physician provider holding M.D. credentials at 220 MERIDIAN AVE, SAN JOSE, CA, 95126, with a listed phone of (408) 869-3403. NPI 1407274913 was issued on 04/01/2014. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what HADI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 504 prescription claims written by this provider, covering 141 Medicare beneficiaries and totaling roughly $51K in drug spend, split 48% brand-name and 52% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.9655/100 for the 2023 performance year (Quality 100, Cost 73.2182), compared with the national average of 83.1.

Retina Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 913 enrolled providers across 48 states and an average of 558 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

220 MERIDIAN AVE
SAN JOSE, CA 95126

Provider Details

NPI 1407274913
Specialty Retina Specialist (Ophthalmology) Physician
Credentials M.D.
Gender Male
NPI Issued 04/01/2014

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

91.9655
Final Score
Avg: 83.1
100
Quality
73.2182
Cost

Reporting: Group practice

Hospital and facility affiliations

Facilities where TAMER HADI, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

BDHV MEDICAL GROUP OF CALIFORNIA PC
SAN JOSE, CA
PERMANENTE MEDICAL GROUP INC
FREMONT, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for TAMER HADI, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$68

Largest payer

Alcon Vision LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to TAMER HADI, M.D.. To verify TAMER HADI, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

TAMER HADI, M.D. — brand share 48.0%
Specialty average (est.)

48% brand-name claims vs 52% generic, on 504 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

504
Total Claims
$51K
Total Drug Cost
141
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
890
Total Day Supply
24,345
Brand vs Generic
48% brand / 52% generic
Brand Drug Cost
$43K
Generic Drug Cost
$8K

Patient Demographics

Average Patient Age
78.2 years
Avg HCC Risk Score
1.43
Gender Split
64% female / 36% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Latanoprost
168
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
51
Erythromycin
Erythromycin Base
50
Timolol Maleate
37
Brimonidine Tartrate
27
Lumigan
Bimatoprost
19
Rhopressa
Netarsudil Mesylate
17
Rocklatan
Netarsudil Mesylat/Latanoprost
16
Simbrinza
Brinzolamide/Brimonidine Tart
16
Vyzulta
Latanoprostene Bunod
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Retina Specialist (Ophthalmology) Physician Overview

How TAMER HADI, M.D. fits within the Retina Specialist (Ophthalmology) Physician landscape nationally.

913
Retina Specialist (Ophthalmology) Physician Providers in US
48
States with Retina Specialist (Ophthalmology) Physician
558
Avg Claims per Provider

TAMER HADI, M.D.'s 504 claims are below the specialty average of 558.

Nearby Retina Specialist (Ophthalmology) Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as HADI.

Compare Retina Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is TAMER HADI, M.D.'s specialty?
TAMER HADI, M.D. specializes in Retina Specialist (Ophthalmology) Physician and practices in SAN JOSE, California. Credentials: M.D..
How much does TAMER HADI, M.D. prescribe under Medicare Part D?
In 2023, TAMER HADI, M.D. wrote 504 Medicare Part D claims totaling $51K in drug costs for 141 beneficiaries.
What is TAMER HADI, M.D.'s Medicare quality score?
TAMER HADI, M.D. has a CMS MIPS Final Score of 91.9655/100 (Quality: 100, Cost: 73.2182). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is TAMER HADI, M.D. located?
TAMER HADI, M.D. is located at 220 MERIDIAN AVE, SAN JOSE, CA, 95126. Phone: (408) 869-3403.
What is TAMER HADI, M.D.'s NPI number?
TAMER HADI, M.D.'s National Provider Identifier (NPI) is 1407274913, issued on 04/01/2014.
Does TAMER HADI, M.D. prescribe more brand-name or generic drugs?
TAMER HADI, M.D.'s prescribing is 48% brand-name and 52% generic drugs by claim count, with $43K in brand drug costs.
How many Retina Specialist (Ophthalmology) Physician providers are there in the US?
There are 913 Retina Specialist (Ophthalmology) Physician providers across 48 states in the US. The average Retina Specialist (Ophthalmology) Physician provider writes 558 Medicare Part D claims per year.
What drugs does TAMER HADI, M.D. prescribe most often?
Based on 2023 Medicare Part D data, TAMER HADI, M.D.'s most frequently prescribed drugs include Latanoprost, Dorzolamide-Timolol, Erythromycin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does TAMER HADI, M.D. accept Medicare?
TAMER HADI, M.D. appears in CMS Medicare data with 504 Part D claims and 141 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify TAMER HADI, M.D.'s credentials?
TAMER HADI, M.D.'s NPI is 1407274913 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology